Be the first person to write a business review for ORIX USA Corporation

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. Experienced partners, who bring together deep domain knowledge in life sciences, have established a proven track record of identifying, validating and backing emerging trends and technologies. While willing to consider an investment in a company at almost any stage, OBP brings unique value and expertise to early-stage situations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide, and has successfully leveraged the extensive research, operating, and financial expertise and experience of its team of investment professionals.

Oxford Technology Management was founded by Lucius Cary, and since 1983 has specialised in making and managing investments in start-up and early stage technology-based businesses with high growth prospects. The OTM team are all scientists or engineers by background, and understanding the technology is the starting point for any investment that we may make. The Investment policy of Oxford Technology Management is to construct a portfolio of investments with the following characteristics: unlisted, UK based, technology businesses, investments typically in the range of £100,000 - £2,000,000, although it can then invest similar amounts in subsequent rounds, in most cases located within easy reach of Oxford to allow a more 'hands on' management strategy. It is expected that approximately half of the funds will be invested in early stage companies (those which have achieved some initial sales) and the balance in start-up companies which are at an earlier stage.

Pacific Venture Group was founded in 1995. Pacific Venture Group is a private equity and venture capital firm specializing in early and expansion-stage investments. The firm seeks to invest in companies at all stages of financing from start-up to leveraged buyout, recapitalizations, and consolidations. It typically invests across all segments of healthcare and information systems including healthcare information technology, medical devices, biopharmaceuticals, and healthcare services. Within healthcare information technology, the firm focuses on infrastructure solutions, leverage professional staffing, technology based outsource solutions, and clinical quality improvement. Within medical devices, it focuses on unmet therapeutic needs and disposables, cost effective medical devices, small equipments, and medical devices that enhance quality of life. Within biopharmaceuticals, the firm invests in drug delivery, drug discovery, specialty pharmaceuticals, and in licensing. Within healthcare services, it focuses on new care delivery models, outsourcing, healthcare staffing solutions, and recapitalizations and spinouts from larger companies.

PAI partners is one of the oldest and most experienced private equity firms in Europe with its origins dating back to Paribas Affaires Industrielles, the historical principal investment activity of Paribas, the pan-European merchant bank which merged with BNP in 1999. PAI partners SAS is an independent company, owned by its partners, which manages and advises dedicated private equity funds. The buyout funds include PAI LBO Fund, PAI Europe III, PAI Europe IV and PAI Europe V. PAI partners has offices in Paris, Copenhagen, London, Luxembourg, Madrid, Milan, Munich. The Europe-wide team is composed of 50 professionals with diverse backgrounds and sectorial expertise.

Palamon Capital Partners was founded in 1999. Palamon Capital Partners is a private equity and venture capital firm specializing in investments in middle market companies. The firm invests in mid and late venture, development capital, recapitalizations, deleveraging transactions, turnarounds, and buyouts. It primarily invests in service sector businesses with a focus on specialty engineering, communications and media, financial services, leisure and entertainment, healthcare, information technology, and business services. The firm invests in companies based in Europe. It seeks to invest between €10 million ($15.45 million) and €80 million ($123.67 million) in its portfolio companies. The firm prefers to be the lead investor with either a majority or significant minority shareholding and at least two board seats in its portfolio companies.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.